Natural history of subclinical hypothyroidism in diabetes mellitus: a prospective observational study

Shailendra Kumar Singh; Rina Singh; Sonam Bedi; Arun Kumar Pandey; Alankar Tiwari; Pradeep Kumar Rai

doi:10.18203/2349-3933.ijam20243062

Authors

Shailendra Kumar Singh Department of Endocrine, Endocrine Clinic, Varanasi, Uttar Pradesh, India https://orcid.org/0000-0001-8840-5691
Rina Singh Department of Endocrine, Endocrine Clinic, Varanasi, Uttar Pradesh, India
Sonam Bedi Department of Community Medicine, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India
Arun Kumar Pandey Department of Endocrine, Lucknow Endocrine Diabetes and Thyroid Clinic, Vivek Khand, Gomti Nagar, Lucknow, Uttar Pradesh, India
Alankar Tiwari Department of Endocrine, Diabetes and Endocrine care Superspeciality clinic, Varanasi, Uttar Pradesh, India
Pradeep Kumar Rai Department of Nephrology, Opal Hospital, Varanasi, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243062

Keywords:

Diabetes mellitus, Overt hypothyroidism, Subclinical hypothyroidism, Thyroid autoimmunity

Abstract

Background: The natural course of subclinical hypothyroidism (SCH) is variable. Several studies have shown that not all SCH progresses to overt hypothyroidism (OH). Little data are available regarding the natural course of SCH in diabetes mellitus (DM). We aimed to investigate the natural course of SCH in DM patients.

Methods: A total of 118 patients with SCH (52 with DM and 66 without DM) were enrolled in this prospective observational study. Anthropometric, thyroid hormone and Anti-thyroid peroxidase (TPO) antibody (Ab) level were measured at baseline. Thyroid hormone levels were also estimated at 6 month and 12 months.

Result: The majority of the patients, 76(61.86%), remained with SCH, 21(17.8%) progressed to OH and 24 (20.83%) reverted to normal. The rate of progression to OH (DM: 7.69% vs non-DM: 25.76%) was significantly lower in patients with diabetes than in those without. Multivariate logistic regression analysis showed that the risk factors for progression to OH were the glycemic status and thyroid autoantibody.

Conclusion: The present study suggests that patient with SCH have variable disease courses. Glycemic status and autoimmunity are the two most powerful predictors of OH. DM protects the progression to OH whereas thyroid autoantibody increases the risk of progression to OH. We recommend a more aggressive follow up for thyroid autoantibody positive and non-diabetic patients.

Metrics

Metrics Loading ...

References

Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr Rev. 2019;40(3):789-824.

Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131.

Perros P, McCrimmon RJ, Shaw G, Frier BM. Fre- quency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12(7): 622-7.

Singh SK, Singh R, Singh A. Prevalence of thyroid disorders (TD) in newly diagnosed type 2 diabetes mellitus patients - a cross sectional study. J Assoc Physicians India. 2021;69(10):11-2.

Jun JE, Jin SM, Jee JH, Bae JC, Hur KY, Lee MK, et al. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects. Endocrine. 2017;55(3):944–95.

Santini F, Marzullo P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014;171(4): R137-52.

Wang T, Xu J, Bo T, Zhou X, Jiang X, Gao L, et al. Decreased fasting blood glucose is associated with impaired hepatic glucose production in thyroid- stimulating hormone receptor knockout mice. Endocr J. 2013;60(8):941-50.

Blanchet E, Bertrand C, Annicotte JS, Schlernitzauer A, Pessemesse L, Levin J, et al. Mitochondrial T3 receptor p43 regulates insulin secretion and glucose homeostasis. FASEB J. 2012;26(1):40-50.

Han C, He X, Xia X, Li Y, Shi X, Shan Z. Subclinical hypothyroidism and type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2015;10(8):135233.

Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011:439463.

Garber JR, Cobin RH, Gharib, H. American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028.

Sgarbi JA, Teixeira PF, Maciel LM, Mazeto GM, Vaisman M, Montenegro Junior RM, et al. The Brazilian consensus for the clinical approach and treatment of subclinical hypothyroidism in adults: recommendations of the thyroid Department of the Brazilian society of endocrinology and metabolism. Arquivos Brasileiros de Endocrinologia and Metabologia. 2013;57:166-83.

Gray RS, Borsey DQ, Irvine WJ, Seth J, Clarke BF. Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled study. Clin Endocrinol (Oxford). 1983;19(4):445–51.

Chubb SA, Davis WA, Inman Z, Davis TM. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the fremantle diabetes study. Clin Endocrinol (Oxf). 2005;62(4):480–6.

Unnikrishnan AG, Menon UV. Thyroid disorders in India: An epidemiological perspective. Indian J Endocrinol Metab. 2011;15(2):78-81.

Singh SK, Singh R, Singh SK. Thyroid dysfunction in India: What is different. Int J Adv Med. 2024;11:286-90.

Singh SK, Singh R, Singh SK, Iquebal MA, Jaiswal S, Rai PK. Risk of progression to overt hypothyroidism in Indian patients with subclinical hypothyroidism: a prospective observational study. Int J Adv Med. 2022;9:1183-7.

Diez JJ, Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab. 2004;89:4890-7.

Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab. 2012;97(6):1962-9.

Park WR, Oh TK, Jeon HJ. Prospective observation of 5-year clinical course of subclinical hypothyroidism in Korean population. J Korean Med Sci. 2013;28(11):1622-6.

Tunbridge WM, Brewis M, French JM, Appleton D, Bird T, Clark F, et al. Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed). 1981;24;282(6260):258-62.

Tudor RM, Garrahy A, Woods CP. The prevalence and incidence of thyroid dysfunction in patients with diabetes- a longitudinal follow-up study. Ir J Med Sci. 2020;189(1):171-5

Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442-9.

Lupoli R, Di Minno A, Tortora A, Ambrosino P, Lupoli GA, Di Minno MN. Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J Clin Endocrinol Metab. 2014;99(1):143-8.

Karimifar M, Aminorroaya A, Amini M, Mirfendereski T, Iraj B, Feizi A, et al. Effect of metformin on thyroid stimulating hormone and thyroid volume in patients with prediabetes: A randomized placebo-controlled clinical trial. J Res Med Sci. 2014;19(11):1019-26.

Li X, Zhen D, Zhao M, Liu L, Guan Q, Zhang H, et al. Natural history of mild subclinical hypothyroidism in a middle-aged and elderly Chinese population: a prospective study. Endocr J. 2017;29;64(4):437-47.

Mach F. Statins as immunomodulatory agents. Circulation. 2004;1;109(1):15-7.

Valensi P, Perret R, Vassy G, Vassy R, Uzzan. Effect of nifedipine on thyrotropin, prolactin, and thyroid hormone release in man: a placebo-controlled study. Fundam Clin Pharmacol. 1989;3(1):59–66.

Imaizumi M, Sera N, Ueki I, Horie I, Ando T, Usa T, et al. Risk for progression to overt hypothyroidism in an elderly Japanese population with subclinical hypothyroidism. Thyroid. 2011;21(11):1177-82.

Huber G, Staub JJ, Meier C, Mitrache C, Guglielmetti M, Huber P, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab. 2002;87:3221-6.

Rosário PW, Carvalho M, Calsolari MR. Natural history of subclinical hypothyroidism with TSH ≤10 mIU/l: a prospective study. Clin Endocrinol (Oxf). 2016;84(6):878-81.